Trial Outcomes & Findings for COACH-Cog Intervention Adaptation Focus Groups (NCT NCT05775991)

NCT ID: NCT05775991

Last Updated: 2024-12-11

Results Overview

Qualitative data gathered from participants during focus group participation. Focus groups will be audio-recorded and transcribed. Transcribed audio-recordings will be qualitatively analyzed for positive regard for the intervention and opportunities and recommendations for further intervention adaptation. Open coding using content analysis framework will be utilized for qualitative analysis.

Recruitment status

COMPLETED

Target enrollment

18 participants

Primary outcome timeframe

Through study completion approximately 3 months

Results posted on

2024-12-11

Participant Flow

Participant milestones

Participant milestones
Measure
Medical Oncologists and Clincians
Individuals practicing as medical oncologists or with expertise in medical oncology. Clinicians with expertise in cognitive impairment and dementia.
Older Patients With Cancer
Older patients with cancer or older survivors of patients with cancer
Caregivers of Patients With Dementia or Cognitive Impairment
Caregivers of patients with dementia or cognitive impairment
Overall Study
STARTED
5
4
9
Overall Study
COMPLETED
5
4
7
Overall Study
NOT COMPLETED
0
0
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Medical Oncologists and Clincians
Individuals practicing as medical oncologists or with expertise in medical oncology. Clinicians with expertise in cognitive impairment and dementia.
Older Patients With Cancer
Older patients with cancer or older survivors of patients with cancer
Caregivers of Patients With Dementia or Cognitive Impairment
Caregivers of patients with dementia or cognitive impairment
Overall Study
Withdrawal by Subject
0
0
2

Baseline Characteristics

COACH-Cog Intervention Adaptation Focus Groups

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Medical Oncologists and Clinicians
n=5 Participants
Individuals practicing as medical oncologists or with expertise in medical oncology. Clinicians with expertise in cognitive impairment and dementia.
Older Patients With Cancer
n=4 Participants
Older patients with cancer or older survivors of patients with cancer
Caregivers of Patients With Dementia or Cognitive Impairment
n=9 Participants
Caregivers of patients with dementia or cognitive impairment
Total
n=18 Participants
Total of all reporting groups
Age, Customized
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Age, Customized
Between 18 and 65 years Between 18 and 65 years Between 18 and 65 years Between 18 and 65 years
4 Participants
n=5 Participants
0 Participants
n=7 Participants
4 Participants
n=5 Participants
8 Participants
n=4 Participants
Age, Customized
>=65 years
0 Participants
n=5 Participants
4 Participants
n=7 Participants
5 Participants
n=5 Participants
9 Participants
n=4 Participants
Age, Customized
Unknown/Missing
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Sex/Gender, Customized
Female
3 Participants
n=5 Participants
2 Participants
n=7 Participants
6 Participants
n=5 Participants
11 Participants
n=4 Participants
Sex/Gender, Customized
Male
1 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
5 Participants
n=4 Participants
Sex/Gender, Customized
Intersex
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Sex/Gender, Customized
None of these describe me
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Sex/Gender, Customized
Prefer not to answer
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
Sex/Gender, Customized
Missing
1 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
1 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
2 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
4 Participants
n=5 Participants
4 Participants
n=7 Participants
6 Participants
n=5 Participants
14 Participants
n=4 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
2 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
2 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
White
2 Participants
n=5 Participants
4 Participants
n=7 Participants
7 Participants
n=5 Participants
13 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
1 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
2 Participants
n=4 Participants

PRIMARY outcome

Timeframe: Through study completion approximately 3 months

Qualitative data gathered from participants during focus group participation. Focus groups will be audio-recorded and transcribed. Transcribed audio-recordings will be qualitatively analyzed for positive regard for the intervention and opportunities and recommendations for further intervention adaptation. Open coding using content analysis framework will be utilized for qualitative analysis.

Outcome measures

Outcome measures
Measure
Medical Oncologists and Clinicians
n=5 Participants
Individuals practicing as medical oncologists or with expertise in medical oncology. Clinicians with expertise in cognitive impairment and dementia.
Older Patients With Cancer
n=4 Participants
Older patients with cancer or older survivors of patients with cancer
Caregivers of Patients With Dementia or Cognitive Impairment
n=9 Participants
Caregivers of patients with dementia or cognitive impairment
Qualitative Analysis of Focus Group Audio-recording Transcripts. Open Coding Using Content Analysis Framework Will be Utilized to Assess Positive Regard for the Intervention and Potential Intervention Adaptations.
Positive Quote Given
4 Participants
3 Participants
4 Participants
Qualitative Analysis of Focus Group Audio-recording Transcripts. Open Coding Using Content Analysis Framework Will be Utilized to Assess Positive Regard for the Intervention and Potential Intervention Adaptations.
Negative Quote Given
0 Participants
0 Participants
0 Participants
Qualitative Analysis of Focus Group Audio-recording Transcripts. Open Coding Using Content Analysis Framework Will be Utilized to Assess Positive Regard for the Intervention and Potential Intervention Adaptations.
Withdrew
0 Participants
0 Participants
2 Participants
Qualitative Analysis of Focus Group Audio-recording Transcripts. Open Coding Using Content Analysis Framework Will be Utilized to Assess Positive Regard for the Intervention and Potential Intervention Adaptations.
No Quote Given Applicable
1 Participants
1 Participants
3 Participants

Adverse Events

Medical Oncologists and Clinicians

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Older Patients With Cancer

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Caregivers of Patients With Dementia or Cognitive Impairment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Allison Magnuson

University of Rochester

Phone: 585-602-5085

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place